Sueda Jun, Sakuma Toshiro, Nakamura Hajime, Usumoto Nari, Okuno Takashi, Arai Mikki, Hirose Tatsuo
Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts, USA.
Invest Ophthalmol Vis Sci. 2006 Mar;47(3):1142-8. doi: 10.1167/iovs.05-0931.
Seprafilm, a sodium hyaluronate/carboxymethylcellulose absorbable barrier developed to prevent adhesions after abdominal surgery, adheres well to wet tissue. The authors studied the efficacy of this film for sealing retinal breaks in animals.
In an in vitro study, a retinal detachment with a hole was created in bovine eyecups after the vitreous gel was removed. Seprafilm was placed over the retinal hole, and the strength of the retinal adhesion was measured by pulling the film. Permeability was tested by applying methylene blue to the film covering the retinal break. Seprafilm also was soaked in balanced salt solution (BSS) incubated at 37 degrees C, and the pH of the BSS containing Seprafilm was measured as it melted. In an in vivo study, Seprafilm was powdered and mixed in BSS solution, and 0.1 mL was injected into the right vitreous cavity in study rabbits. The same amount of BSS was injected into the right vitreous cavity in control rabbits. Ophthalmologic examinations were performed. Bilateral electroretinograms were recorded simultaneously before and 6 weeks after injection. Both eyes were enucleated for histologic evaluation.
Seprafilm adhered well to the retina, was impermeable to methylene blue, and remained solid in BSS for 30 days before it dissolved, and its pH ranged from 7.2 to 8.0. No intraocular inflammatory reaction occurred after intravitreous injection of Seprafilm solution. There was no significant difference in amplitudes or implicit times of electroretinogram a-waves, b-waves, and oscillatory potentials before and after injection and between study and control groups. No significant retinal abnormality was detected by light microscopy in either group.
The film adhered well to the retina with no signs of ocular toxicities. Further study is warranted for possible means of patching retinal breaks.
Seprafilm是一种为预防腹部手术后粘连而研发的透明质酸钠/羧甲基纤维素可吸收屏障,它能很好地粘附于湿润组织。作者研究了该薄膜在动物中封闭视网膜裂孔的疗效。
在一项体外研究中,去除牛眼杯中的玻璃体凝胶后制造一个带孔的视网膜脱离。将Seprafilm置于视网膜裂孔上,通过牵拉薄膜测量视网膜粘连强度。通过向覆盖视网膜裂孔的薄膜上涂抹亚甲蓝来测试其渗透性。Seprafilm也浸泡在37℃孵育的平衡盐溶液(BSS)中,测量含Seprafilm的BSS融化时的pH值。在一项体内研究中,将Seprafilm粉末化并与BSS溶液混合,向研究兔的右眼玻璃体腔注射0.1mL。向对照兔的右眼玻璃体腔注射等量的BSS。进行眼科检查。在注射前和注射后6周同时记录双侧视网膜电图。摘除双眼进行组织学评估。
Seprafilm与视网膜粘附良好,对亚甲蓝不透,在BSS中溶解前30天保持固态,其pH值在7.2至8.0之间。玻璃体腔内注射Seprafilm溶液后未发生眼内炎症反应。注射前后以及研究组和对照组之间视网膜电图a波、b波和振荡电位的振幅或隐含时间无显著差异。两组光镜下均未检测到明显的视网膜异常。
该薄膜与视网膜粘附良好,无眼毒性迹象。对于修补视网膜裂孔的可能方法,有必要进行进一步研究。